Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-21 Sale |
2025-03-25 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
9,766 | $293.36 | $2,864,985 | 20,902 (Indirect Direct) |
View |
2025-03-03 Sale |
2025-03-05 4:21 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
2,557 | $242.92 | $621,150 | 33,042 (Indirect Direct) |
View |
2025-02-28 Sale |
2025-03-03 4:31 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
935 | $241.69 | $225,977 | 15,551 (Indirect Direct) |
View |
2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,109 | $253.43 | $787,904 | 12,670 (Indirect Direct) |
View |
2025-01-27 Sale |
2025-01-29 4:03 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
52,592 | $285 | $14,988,720 | 12,670 (Indirect Direct) |
View |
2024-12-12 Sale |
2024-12-13 4:13 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,752 | $251 | $439,760 | 16,386 (Indirect Direct) |
View |
2024-11-26 Sale |
2024-11-27 5:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,682 | $250.98 | $422,144 | 18,138 (Indirect Direct) |
View |
2024-06-25 Sale |
2024-06-26 4:28 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
2,103 | $230.99 | $485,773 | 16,290 (Indirect Direct) |
View |
2024-02-28 Sale |
2024-02-29 4:17 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
574 | $155.3 | $89,145 | 13,163 (Indirect Direct) |
View |
2024-02-16 Sale |
2024-02-20 4:09 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,308 | $148.06 | $193,666 | 8,013 (Indirect Direct) |
View |
2023-08-04 Sale |
2023-08-07 6:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
7,627 | $184.78 | $1,409,306 | 5,026 (Indirect Direct) |
View |
2023-04-27 Sale |
2023-04-28 5:54 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,294 | $197.12 | $846,450 | 5,026 (Indirect Direct) |
View |
2023-03-03 Sale |
2023-03-07 4:07 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
18,072 | $200 | $3,614,400 | 5,026 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-24 Exercise |
2025-03-25 4:10 pm |
N/A 2026-12-20 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
5,445 | $0 | 20,902 (Direct) |
View |
2025-03-24 Exercise |
2025-03-25 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
5,445 | $42.22 | 20,902 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:21 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
21,956 | $0 | 33,042 (Direct) |
View |
2025-02-27 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,908 | $0 | 15,551 (Direct) |
View |
2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,109 | $0 | 12,670 (Direct) |
View |
2025-01-27 Exercise |
2025-01-29 4:03 pm |
2019-08-06 2025-12-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
48,876 | $0 | 12,670 (Direct) |
View |
2025-01-27 Exercise |
2025-01-29 4:03 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
48,876 | $88.95 | 12,670 (Direct) |
View |
2024-11-25 Option Award |
2024-11-27 5:22 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
3,434 | $0 | 18,138 (Direct) |
View |
2024-10-08 Option Award |
2024-10-10 4:06 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
96 | $0 | 16,386 (Direct) |
View |
2024-06-24 Option Award |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,295 | $0 | 16,290 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 4:21 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
14,030 | $0 | 23,377 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:17 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,908 | $0 | 13,163 (Direct) |
View |
2024-02-15 Option Award |
2024-02-20 4:09 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,295 | $0 | 8,013 (Direct) |
View |
2023-08-03 Option Award |
2023-08-07 6:05 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
7,627 | $0 | 5,026 (Direct) |
View |
2023-06-14 Option Award |
2023-06-15 4:43 pm |
N/A 2033-06-13 |
SQZ Biotechnologies Co | SQZ | Garg Pushkal Director |
39,875 | $0 | 39,875 (Direct) |
View |
2023-04-26 Option Award |
2023-04-28 5:54 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,294 | $0 | 5,026 (Direct) |
View |
2023-03-03 Exercise |
2023-03-07 4:07 pm |
2018-08-11 2024-12-17 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
5,000 | $0 | 5,026 (Direct) |
View |
2023-03-03 Exercise |
2023-03-07 4:07 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
2,500 | $96.45 | 5,026 (Direct) |
View |
2023-02-27 Option Award |
2023-03-01 4:22 pm |
N/A 2026-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
17,574 | $0 | 17,574 (Direct) |
View |
2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
165 | $205.87 | 18,098 (Direct) |
View |
2022-08-03 Option Award |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
11,311 | $0 | 18,098 (Direct) |
View |
2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
146 | $210.02 | 18,098 (Direct) |
View |
2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,603 | $189.76 | 18,098 (Direct) |
View |
2022-08-04 Tax Withholding |
2022-08-05 4:14 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
172 | $209.91 | 18,098 (Direct) |
View |
2022-06-15 Option Award |
2022-06-16 5:01 pm |
N/A 2032-06-14 |
SQZ Biotechnologies Co | SQZ | Garg Pushkal Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-02-23 Option Award |
2022-02-25 4:12 pm |
N/A 2032-02-22 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
24,128 | $0 | 24,128 (Direct) |
View |
Ownership |
2022-01-04 4:03 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
0 | $0 | 186,411 (Direct) |
View |
2021-06-15 Option Award |
2021-06-17 5:16 pm |
N/A 2031-06-14 |
SQZ Biotechnologies Co | SQZ | Garg Pushkal Director |
10,500 | $0 | 10,500 (Direct) |
View |
2020-10-29 Option Award |
2020-10-30 6:35 pm |
N/A 2030-10-28 |
SQZ Biotechnologies Co | SQZ | Garg Pushkal Director |
7,055 | $0 | 7,055 (Direct) |
View |
Ownership |
2020-10-29 8:51 pm |
N/A 2028-11-06 |
SQZ Biotechnologies Co | SQZ | Garg Pushkal Director |
0 | $0 | 44,752 (Direct) |
View |